Study of measles immunisatio
Completed
- Conditions
- Infections and InfestationsHIV infectionHIV infection, measles, children
- Registration Number
- ISRCTN07638533
- Lead Sponsor
- Johns Hopkins University Bloomberg School of Public Health (USA)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 700
Inclusion Criteria
1. Children aged two to eight months (either sex) presenting for well-child care
2. Reside within 10 miles of the study clinic
3. Parents or caretakers provide signed informed consent
Exclusion Criteria
Children with severe illness.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary neutralising antibody responses and persistence of neutralising antibodies following measles vaccination of HIV-1-infected and uninfected children.
- Secondary Outcome Measures
Name Time Method Seroconversion after measles vaccination of HIV-1-infected and uninfected children.